These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 16145220)
41. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data. Lõivukene K; Sepp E; Adamson V; Mitt P; Kallandi U; Otter K; Naaber P Scand J Infect Dis; 2006; 38(11-12):1001-8. PubMed ID: 17148068 [TBL] [Abstract][Full Text] [Related]
42. Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit. Chastre J; Luyt CE; Combes A; Trouillet JL Clin Infect Dis; 2006 Sep; 43 Suppl 2():S75-81. PubMed ID: 16894519 [TBL] [Abstract][Full Text] [Related]
46. Epidemiology of gram-negative conjunctivitis in neonatal intensive care unit patients. Chen CJ; Starr CE Am J Ophthalmol; 2008 Jun; 145(6):966-970. PubMed ID: 18378213 [TBL] [Abstract][Full Text] [Related]
47. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)]. Zarakolu P; Hasçelik G; Unal S Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842 [TBL] [Abstract][Full Text] [Related]
48. Microbiological surveillance in the intensive care unit: a tertiary hospital experience. Akcam FZ; Karaaslan D; Dogan M; Yayli G Med Sci Monit; 2006 Feb; 12(2):CR81-5. PubMed ID: 16449952 [TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetic/pharmacodynamic modeling to predict in vivo effectiveness of various dosing regimens of piperacillin/tazobactam and piperacillin monotherapy against gram-negative pulmonary isolates from patients managed in intensive care units in 2002. Frei CR; Burgess DS Clin Ther; 2008 Dec; 30(12):2335-41. PubMed ID: 19167592 [TBL] [Abstract][Full Text] [Related]
50. Role of unit-specific combination antibiograms for improving the selection of appropriate empiric therapy for gram-negative pneumonia. Pogue JM; Alaniz C; Carver PL; Pleva M; Newton D; DePestel DD Infect Control Hosp Epidemiol; 2011 Mar; 32(3):289-92. PubMed ID: 21460516 [TBL] [Abstract][Full Text] [Related]
52. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa. Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158 [TBL] [Abstract][Full Text] [Related]
53. Cost of Gram-negative resistance. Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877 [TBL] [Abstract][Full Text] [Related]
54. [Determination of sensitivity of the sputum microflora to antibiotics during treatment of pneumonia]. Urbaniuk KG; Kubyshkin VF; Azriel' BK; Kol'chenko TP Vrach Delo; 1974 Dec; (12):48-50. PubMed ID: 4155551 [No Abstract] [Full Text] [Related]
55. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Alvarez-Lerma F Intensive Care Med; 1996 May; 22(5):387-94. PubMed ID: 8796388 [TBL] [Abstract][Full Text] [Related]
56. Aminoglycosides in the intensive care unit: an old drug in a dynamic environment. Miyagawa CI New Horiz; 1993 May; 1(2):172-80. PubMed ID: 7922400 [TBL] [Abstract][Full Text] [Related]
57. Update on the treatment of Pseudomonas aeruginosa pneumonia. El Solh AA; Alhajhusain A J Antimicrob Chemother; 2009 Aug; 64(2):229-38. PubMed ID: 19520717 [TBL] [Abstract][Full Text] [Related]
58. Impact of an institution-specific hospital-acquired pneumonia protocol on the appropriateness of antibiotic therapy and patient outcomes. Lancaster JW; Lawrence KR; Fong JJ; Doron SI; Garpestad E; Nasraway SA; Devlin JW Pharmacotherapy; 2008 Jul; 28(7):852-62. PubMed ID: 18576900 [TBL] [Abstract][Full Text] [Related]
59. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA). Rhomberg PR; Fritsche TR; Sader HS; Jones RN Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338 [TBL] [Abstract][Full Text] [Related]